Medindia LOGIN REGISTER
Medindia

Study Explores Prevalence, Risk Factors for Diabetic Macular Edema

by Himabindu Venkatakrishnan on Aug 20 2014 11:16 AM

Racial differences are seen in the prevalence of diabetic macular edema and among individuals having diabetes for a longer time and higher levels of hemoglobin A1c.

 Study Explores Prevalence, Risk Factors for Diabetic Macular Edema
Racial differences are seen in the prevalence of diabetic macular edema and among individuals having diabetes for a longer time and higher levels of hemoglobin A1c.
Bottom Line: The odds of having diabetic macular edema (DME), a leading cause of vision loss in patients with diabetes mellitus, appears to be higher in non-Hispanic black patients than white patients, as well as in those individuals who have had diabetes longer and have higher levels of hemoglobin A1c.

Author: Rohit Varma, M.D., M.P.H., of the University of Southern California, Los Angeles, and colleagues.

Background: About 347 million people worldwide have diabetes and diabetic eye disease is a leading cause of vision loss in patients between the ages of 20 and 74 years. Although the prevalence of diabetic retinopathy (DR) has been well characterized, less is known about the prevalence of DME among patients with diabetes in the United States.

How the Study Was Conducted: The authors sought to estimate the prevalence of DME, as well as factors associated with the condition in adults. The study was an analysis of 1,038 patients age 40 and older with diabetes and valid eye photographs in the 2005 to 2008 National Health and Nutrition Examination Survey.

Results: Of the 1,038 individuals, 55 of them had DME, for an overall prevalence of 3.8 percent or estimated to be approximately 746,000 people in the 2010 U.S. population age 40 or older. There were no differences in prevalence by age or sex. But other factors associated with higher odds of having the condition include being non-Hispanic black, having diabetes longer and having higher levels of hemoglobin A1c.

Discussion: "Given recent treatment advances in reducing vision loss and preserving vision in DME, it is imperative that all persons with diabetes receive early screening; this recommendation is even more important for those individuals at higher risk for DME."

Advertisement
Source-Eurekalert


Advertisement